- Home
- MSAI vs CLDI Comparison
MSAI vs CLDI Comparison
Compare MSAI & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSAI
- CLDI
- Stock Information
- Founded
- MSAI 1995
- CLDI 2014
- Country
- MSAI United States
- CLDI United States
- Employees
- MSAI N/A
- CLDI N/A
- Industry
- MSAI
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSAI
- CLDI Health Care
- Exchange
- MSAI Nasdaq
- CLDI Nasdaq
- Market Cap
- MSAI 23.6M
- CLDI 20.2M
- IPO Year
- MSAI N/A
- CLDI N/A
- Fundamental
- Price
- MSAI $0.78
- CLDI $5.30
- Analyst Decision
- MSAI Strong Buy
- CLDI
- Analyst Count
- MSAI 1
- CLDI 0
- Target Price
- MSAI $2.50
- CLDI N/A
- AVG Volume (30 Days)
- MSAI 109.3K
- CLDI 961.3K
- Earning Date
- MSAI 08-13-2025
- CLDI 08-08-2025
- Dividend Yield
- MSAI N/A
- CLDI N/A
- EPS Growth
- MSAI N/A
- CLDI N/A
- EPS
- MSAI N/A
- CLDI N/A
- Revenue
- MSAI $5,591,000.00
- CLDI N/A
- Revenue This Year
- MSAI $66.87
- CLDI N/A
- Revenue Next Year
- MSAI $81.01
- CLDI N/A
- P/E Ratio
- MSAI N/A
- CLDI N/A
- Revenue Growth
- MSAI N/A
- CLDI N/A
- 52 Week Low
- MSAI $0.52
- CLDI $2.43
- 52 Week High
- MSAI $3.33
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- MSAI 51.67
- CLDI 44.17
- Support Level
- MSAI $0.76
- CLDI $4.85
- Resistance Level
- MSAI $0.84
- CLDI $6.06
- Average True Range (ATR)
- MSAI 0.05
- CLDI 1.03
- MACD
- MSAI -0.00
- CLDI -0.31
- Stochastic Oscillator
- MSAI 57.14
- CLDI 8.91
About MSAI Infrared Cameras Holdings Inc.
MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.